BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38452440)

  • 21. The effects of TNF-α/TNFR2 in regulatory T cells on the microenvironment and progression of gastric cancer.
    Qu Y; Wang X; Bai S; Niu L; Zhao G; Yao Y; Li B; Li H
    Int J Cancer; 2022 Apr; 150(8):1373-1391. PubMed ID: 34766338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TNFR2-expressing CD4
    He J; Li R; Chen Y; Hu Y; Chen X
    Prog Mol Biol Transl Sci; 2019; 164():101-117. PubMed ID: 31383403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Migration of regulatory T cells toward airway epithelial cells is impaired in chronic rhinosinusitis with nasal polyposis.
    Kim YM; Munoz A; Hwang PH; Nadeau KC
    Clin Immunol; 2010 Oct; 137(1):111-21. PubMed ID: 20598643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deficiency of INPP4A promotes M2 macrophage polarization in eosinophilic chronic rhinosinusitis with nasal polyps.
    Xu Y; Tong X; Liu P; Huang J; Chen S; Liu D; Gu T; Xie Y; Guo D; Xu Y
    Inflamm Res; 2024 Apr; 73(4):581-595. PubMed ID: 38363325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increase of high mobility group box chromosomal protein 1 in eosinophilic chronic rhinosinusitis with nasal polyps.
    Chen D; Mao M; Bellussi LM; Passali D; Chen L
    Int Forum Allergy Rhinol; 2014 Jun; 4(6):453-62. PubMed ID: 24504744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor necrosis factor-α receptor expression correlates with mucosal changes and biofilm presence in chronic rhinosinusitis with nasal polyposis.
    Karosi T; Csomor P; Sziklai I
    Laryngoscope; 2012 Mar; 122(3):504-10. PubMed ID: 22231697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of Budesonide Nasal Spray on Neutrophilic Chronic Rhinosinusitis with Nasal Polyps: A Combined Clinical and Experimental Study.
    Lin L; Lan J; Dai F; Wei J; Chen Z; Sun G
    Int Arch Allergy Immunol; 2020; 181(7):551-562. PubMed ID: 32369807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulatory T cells express Tumor Necrosis Factor Receptor 2 with the highest intensity among CD4
    Ghods A; Mehdipour F; Shariat M; Talei AR; Ghaderi A
    Mol Immunol; 2021 Sep; 137():52-56. PubMed ID: 34214829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased expression of TIPE2 in alternatively activated macrophages is associated with eosinophilic inflammation and disease severity in chronic rhinosinusitis with nasal polyps.
    Yao Y; Wang ZC; Liu JX; Ma J; Chen CL; Deng YK; Liao B; Wang N; Wang H; Ning Q; Liu Z
    Int Forum Allergy Rhinol; 2017 Oct; 7(10):963-972. PubMed ID: 28665518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease.
    Zhang N; Van Zele T; Perez-Novo C; Van Bruaene N; Holtappels G; DeRuyck N; Van Cauwenberge P; Bachert C
    J Allergy Clin Immunol; 2008 Nov; 122(5):961-8. PubMed ID: 18804271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Retrospective Analysis of γδ T Cell Expression in Chronic Rhinosinusitis and Its Association with Recurrence of Nasal Polyps.
    Lee W; Chang L; Huang Z; Huang J; Yang L; Wang Z; Zhang G
    ORL J Otorhinolaryngol Relat Spec; 2017; 79(5):251-263. PubMed ID: 28858878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The current findings in eosinophilic chronic rhinosinusitis.
    Tsuda T; Suzuki M; Kato Y; Kidoguchi M; Kumai T; Fujieda S; Sakashita M
    Auris Nasus Larynx; 2024 Feb; 51(1):51-60. PubMed ID: 37574421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Expression of PPAR-γ in patients with chronic rhinosinusitis without or with nasal polyps].
    Peng X; Kong W; Wang Y
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Oct; 28(20):1602-5. PubMed ID: 25764763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of Oxidative Stress and Inflammation-Related Genes in Nasal Mucosa and Nasal Polyps from Patients with Chronic Rhinosinusitis.
    Mihalj H; Butković J; Tokić S; Štefanić M; Kizivat T; Bujak M; Baus Lončar M; Mihalj M
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of Chronic Rhinosinusitis With Nasal Polyps in Endotypes of Dermatophagoides pteronyssinus-Induced Rhinitis.
    De Marchi S; Cecchin E; De Marchi SU; Iuri F; Sechi LA
    J Allergy Clin Immunol Pract; 2022 Jun; 10(6):1506-1514.e2. PubMed ID: 35074602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytokine Signature and Involvement in Chronic Rhinosinusitis with Nasal Polyps.
    Carsuzaa F; Béquignon É; Dufour X; de Bonnecaze G; Lecron JC; Favot L
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aspergillus fumigatus-Specific T Cells in Patients with Chronic Rhinosinusitis.
    Ickrath P; Sprügel L; Beyersdorf N; Haug L; Scherzad A; Hagen R; Hackenberg S
    Int Arch Allergy Immunol; 2023; 184(5):502-512. PubMed ID: 36652922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nasal polyps and rhinosinusitis.
    Kwah JH; Peters AT
    Allergy Asthma Proc; 2019 Nov; 40(6):380-384. PubMed ID: 31690375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic rhinosinusitis precipitated by tumor necrosis factor alpha inhibitors is the phenotype of chronic rhinosinusitis without nasal polyps.
    Papagiannopoulos P; Devins K; Tong CCL; Yver C; Patel NN; Kuhar HN; Bosso JV; Kohanski MA; Tajudeen BA; Kuan EC; Batra PS; Cohen NA; Kennedy DW; Palmer JN; Montone K; Adappa ND
    Int Forum Allergy Rhinol; 2020 Jan; 10(1):23-28. PubMed ID: 31794110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nuclear Factor κB/MicroRNA-155 Upregulates the Expression Pattern of Cytokines in Regulating the Relapse of Chronic Sinusitis with Nasal Polyps and the Underlying Mechanism of Glucocorticoid.
    Du J; Lv H; Dou X; Cao Z
    Med Sci Monit; 2020 Jul; 26():e923618. PubMed ID: 32614806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.